Remembering David Farrell

In commemoration of Brain Cancer Awareness Month, Veritas Medical Solutions, a leading global provider of Radiation Shielding Solutions, reflects on a poignant chapter that became intimately tied to the company’s mission. Five years ago, the cause of brain cancer struck at the heart of Veritas when its Co-Founder & CEO, David Farrell, received a devastating diagnosis of GBM (glioblastoma multiforme).

In a mere span of approximately 13 months, 2017, David, a guiding force and embodiment of Veritas Core Values of Vision, Excellence, Respect, Integrity, Achieve, Serve—departed, leaving a profound impact on the organization. His unwavering commitment to these values reverberates through Veritas’s ongoing efforts and initiatives.

David’s legacy serves as a catalyst for Veritas’s continued dedication to its mission. Through the lens of his vision and values, Veritas remains resolute in its pursuit of alleviating the plight of cancer patients globally. Building upon his legacy, the company persistently contributes to the establishment of Cancer Treatment Centers of Excellence, aiming not only to alleviate suffering but also to elevate the standard of care for individuals battling cancer worldwide.

The loss of David Farrell galvanized Veritas, fortifying their resolve to make a meaningful difference in the lives of those affected by cancer. His spirit permeates the company’s ethos, driving their unwavering commitment to delivering innovative solutions and support to cancer treatment facilities and patients.

During this month of awareness and remembrance, Veritas honors David Farrell’s memory by renewing its pledge to further his legacy. The company channels his passion and values into action, striving to be at the forefront of advancements in radiation shielding solutions and the creation of comprehensive cancer care centers, nurturing hope and progress in the fight against cancer.

Brain Cancer Awareness Month is not only a time to remember but also a reminder of Veritas’s enduring commitment to David’s vision—standing as a beacon of hope and support for cancer patients and their families across the globe.